Jun 18, 2020
Nephrologists Are Hesitant to Fully Embrace Janssen's INVOKANA Despite Being the First and Only SGLT2 Inhibitor with an FDA Indication to Treat Diabetic Kidney Disease
Jun 15, 2020
Ardelyx Announces Positive Second Data Analysis from Ongoing NORMALIZE Phase 4 Study Evaluating Tenapanor in CKD Patients on Dialysis
Jun 12, 2020
KidneyIntelX(TM) Receives New York State Approval to Commence Commercial Testing
Jun 11, 2020
Real-World Data of Terlipressin in Hospitalized Patients in U.K. with Hepatorenal Syndrome Type 1 (HRS-1) Published in Alimentary Pharmacology and Therapeutics
May 28, 2020
Bird Rock Bio Files IND Application for Phase 2 Study of Nimacimab for Treatment of Renal Diseases
May 27, 2020
Kantum Pharma Highlights New Research Demonstrating Beneficial Effects of P2Y14 Antagonist in Acute Kidney Injury
May 20, 2020
European Medicines Agency Accepts Astellas' Marketing Authorization Application for Roxadustat
May 20, 2020
HemaFlo Therapeutics Provides Update on Global Patent Portfolio
May 18, 2020
Global Focal Segmental Glomerulosclerosis (FSGS) Industry Report 2020 - Epidemiology, Pipeline, Drugs, KOL Views, Companies and Outlook to 2030
May 18, 2020
Akebia Therapeutics Announces Collaboration Partner's Submission of Supplemental New Drug Application for Use of Riona® (ferric citrate hydrate) to Treat Adult Patients with Iron Deficiency Anemia in Japan
May 14, 2020
Regulus Therapeutics Reports First Quarter 2020 Financial Results and Recent Updates
May 13, 2020
End Stage Renal Disease Market Size Worth $172.0 Billion by 2027: Grand View Research, Inc.
May 12, 2020
Worldwide Glomerulonephritis Market Insights, 2016-2019 & 2020-2024
May 07, 2020
Global Metabolic Acidosis Market Insights & Epidemiology Assessment 2017-2030
Apr 30, 2020
US Societal Economic Burden of an Inherited Kidney Disease Estimated at $7-10 Billion
Apr 30, 2020
Global Acute Kidney Injury (AKI) Industry Assessment, 2017-2030: Market Size, Drivers & Barriers, Unmet Needs, Emerging Drugs, Market Share of Individual Therapies
Apr 28, 2020
SeaStar Medical to Initiate a Pilot Study of Selective Cytopheretic Device in COVID-19 patients with Acute Respiratory Distress Syndrome and Acute Kidney Injury
Apr 20, 2020
KidneyIntelX(TM) to Predict Major Adverse Kidney Events in COVID-19 Patients
Apr 15, 2020
FDA Approves First Therapy for Treatment of Low-Grade Upper Tract Urothelial Cancer
Mar 19, 2020
Novel Coronavirus Presents Unique Challenges for Hospital Staff and Patients in Isolation